Search Results - "Bardenhagen, Jan"
-
1
Total Pancreatectomy Is a Questionable Choice for Treatment of Chronic Pancreatitis
Published in Journal of the American College of Surgeons (01-06-2024)Get full text
Journal Article -
2
Pancreatic Metastasis from Endometrial Carcinoma
Published in Journal of gastrointestinal surgery (01-02-2019)Get full text
Journal Article -
3
Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma
Published in Clinical chemistry (Baltimore, Md.) (01-03-2023)“…KRAS circulating tumor DNA (ctDNA) has shown biomarker potential for pancreatic ductal adenocarcinoma (PDAC) but has not been applied in clinical routine yet…”
Get full text
Journal Article -
4
Simultaneous Distal Pancreatic Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis in Adenocarcinoma of the Pancreas - A Case Report
Published in Chirurgia (Bucharest, Romania : 1990) (01-07-2022)“…Pancreatic cancer remains one of the biggest challenges in oncology, as most patients are diagnosed in a stage of regional lymphatic or systemic spread of the…”
Get full text
Journal Article -
5
-
6
Peripheral and portal venous KRAS ctDNA detection as independent prognostic markers of early tumour recurrence in pancreatic ductal adenocarcinoma
Published in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (05-11-2023)Get full text
Journal Article -
7
Perioperative management of pancreatic exocrine insufficiency-evidence-based proposal for a paradigm shift in pancreatic surgery
Published in HPB (Oxford, England) (01-01-2024)“…Despite exocrine pancreatic insufficiency (EPI) being a significant consequence of pancreatic surgery, there is still no consensus on its perioperative…”
Get full text
Journal Article -
8
IL-22BP controls the progression of liver metastasis in colorectal cancer
Published in Frontiers in oncology (31-05-2023)“…The immune system plays a pivotal role in cancer progression. Interleukin 22 binding protein (IL-22BP), a natural antagonist of the cytokine interleukin 22…”
Get full text
Journal Article